Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager.
Bryan will be responsible for the company’s day-to-day Canadian operations, leading the Production, IT, HR, Supply Chain and Engineering groups, in coordination with the Quality/Regulatory and Business Development teams. In his new role, Bryan will also participate in strategic planning to support the company’s growth, development and newly unified global operations.
“Bryan brings strong knowledge and capabilities to his new role as General Manager of Phyton Biotech. I look forward to working closely with him as we advance our company’s market position as a biotechnology leader,” said Colin Marr, president of Phyton Biotech. “We are committed to providing pharmaceutical products and services that meet the highest global safety standards and regulations and to developing innovative solutions that respond to our clients’ unique challenges. Bryan’s leadership will be integral to our company’s evolution as a growing and successful CDMO.”
Bryan joined Phyton Biotech in 2011 and previously served as Financial Controller, providing leadership for all financial related activities for the company, including operating planning/budgeting, reporting, accounting, analysis and compliance with regulatory requirements and company policies. Bryan played an active role in providing oversight with executive management of Logistics, IT, and HR and creating strategic and operational plans and goals for the organization.
As a biotechnology leader, Phyton has a successful track record of developing and implementing innovative contract solutions based on plant cell culture development for clients around the world using our revolutionary and proprietary Plant Cell Fermentation (PCF®) platform. We offer comprehensive services for the development and commercialization of plant-based molecules, extracts and recombinant products, serving the Pharmaceutical, Traditional Chinese Medicine, Cosmetic, Agricultural and Food Ingredient Industries.